The Dow just scraped a record high on Wednesday while other indexes fell, led down by the Russell 2000 — the key index of stocks with a small market capitalization.
But don’t think the little guys are giving up just yet.
Our call of the day is from the financial research specialists at Leuthold Group, led by Doug Ramsey, James Paulsen, and Scott Opsal. They say that “a long-term leadership cycle” in small-cap stocks is under way — and it may be bad news for big indexes.
The Russell 2000
continues to register “ridiculously overbought” readings based on many technical factors, the researchers say, and that could be cause for market caution in the short-term. But the “extreme strength” of the index supports the Leuthold Group’s view that dominance in these stocks is here to stay.
Small-cap performance in January pushed the six-month total-return spread between the Russell 2000 and the S&P 500
above 25% for just the eighth time since 1960.
Now, here’s the kicker: In all of the seven past cases, it was only early or midway through a cycle where small-caps led stocks that the relative strength of the Russell 2000 breached the 25% mark.
That means more is likely to come, but it may not be a healthy sign for the stock market overall.
Since 1960, annualized returns for the S&P 500 were almost 6% lower when small-cap stocks have led. In fact, the researchers at Leuthold say that a portfolio of 50% cash and 50% small-caps could match the S&P 500’s volatility in the next few years while actually exceeding its return.
The backdrop of rising yields is also unlikely to derail this trajectory, the researchers say. Small-cap stocks have actually shown “a decisive performance edge” during recent periods when stock prices and bond yields moved in sync.
Bumble is set for an initial public offering on the Nasdaq that could bring in $2.2 billion, with the shares priced at $43 each. The company’s popular namesake dating app requires women to make the first move.
It’s Thursday, and that means job reports on the economic front. Both initial and continuing jobless claims are due at 8:30 a.m. Eastern. The median forecast is that 760,000 Americans filed for unemployment last week.
Shares in Canadian cannabis company Tilray
rocketed 50% higher on Wednesday, extending gains from Tuesday, and are up another 15% or so in the premarket. It appears to be the latest heavily-shorted stock targeted by investors from the Reddit group WallStreetBets — the crowd behind the GameStop frenzy.
President Joe Biden held his first call with Chinese leader Xi Jinping. The White House said Biden pressed Xi on China’s “coercive and unfair economic practices,” as well as human rights issues in Xinjiang and anti-democracy crackdowns in Hong Kong.
Researchers have found that a diabetes treatment can tackle obesity. The drug in question led to 10% weight loss in most trial participants, and 20% in over a third. “This is the start of a new era,” one of the researchers said.
Stock market futures
are slightly higher, set for a buoyant open with the Dow pointing up around 90 points after eking out a higher close on Wednesday. Markets are mostly subdued: Trading in China, Japan and South Korea has stopped for new-year celebrations. European markets
Wolf Richter from the popular Wolf Street financial blog has our charts of the day. He compares global revenues against market capitalization for U.S. automobile makers General Motors
following earnings reports from all three companies.
Tesla stock represents what Richter calls “a class-act ludicrous-mode WTF moment” in markets. He points out that the stock gave up $78 billion in market value in the 11 trading days since Jan. 26 — more than GM’s entire market cap.
“It’s pretty metal,” says a man who turned his uncle’s skeleton into a guitar.
An ancient hunter-gatherer conch shell sounds near-perfect notes after 17,000 years.
Need to Know starts early and is updated until the opening bell, but sign up here to get it delivered once to your email box. The emailed version will be sent out at about 7:30 a.m. Eastern.
Want more for the day ahead? Sign up for The Barron’s Daily, a morning briefing for investors, including exclusive commentary from Barron’s and MarketWatch writers.